NCT03845218View on ClinicalTrials.gov

Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

July 19, 2023

Study Completion Date

July 19, 2023

Conditions
Retinitis Pigmentosa
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT03845218 - Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures | Biotech Hunter | Biotech Hunter